Rodney J Ho

Exec Dir & Porf U Washington; Medical & Pharm Sci; Serial Entrepreneur, Educator. Expt on Inf Diseases, Cancer & AIDS Long-acting drug dev. Exec Dir WE-REACH

[Rodney J Ho @RJ_Ho1]

Announcement of my colleague and @WEREACH1 leadership member David Baker of @UW is one of the 3 recipient of the 2024 Nobel Prize in Chemistry https://t.co/PqMSOo2h0p via @YouTube. #Congratulations.

[Rodney J Ho @RJ_Ho1]

I am pleased to share that #UniversityofWashington #UWSOP TLC-ART team's innovative #long-acting #HIV #treatment containing 3 drug-in-one injectable product has reach #phase1 clinical testing. Please inquire #UWPositiveHIVresearch
about TLC-ART program. https://t.co/bwcVWMFsnc

[WE-REACH @WEREACH1]

The TLC-ART program is seeking healthy volunteers for phase 1 studies for TLC-ART 101, a low dose, long-acting combination of 3 current HIV drugs (tenofovir, ritonavir, and lopinavir). Please contact UW Positive Research at 306-773-7129 to volunteer!

#hiv #therapeutics #aids

[Rodney J Ho @RJ_Ho1]

https://t.co/HgLdrZi8Ff

[Rodney J Ho @RJ_Ho1]

@TheBingle

[Rodney J Ho @RJ_Ho1]

Excited to share TLC-ART in discovery of targeted and #HIV drug combination technology to clinical stage #LA-DcNP #HARRT product for #PLWH thanks to #NIH #Unitaid #MPP. #ICTMM 2020

[Rodney J Ho @RJ_Ho1]

@AmySnover Congratulation Amy

[WE-REACH @WEREACH1]

The Fall 2022 WE-REACH Research Funding Announcement is now live! Declarations of Intent are due September 1st. Learn more here: https://t.co/XeFm1toR4U
#LifeSciences #biotech #commercialization @UWproteindesign @UWCoMotion @ITHS_UW @UW_Pharmacy

[Rodney J Ho @RJ_Ho1]

Exciting New! Congratulation to @ImpelPharma Team. Very Proud. Helping people with #Neurological #diseases and #symptoms. Impel Pharmaceuticals Rings The Closing Bell | NASDAQ https://t.co/Rt7YrEHH79

[Rodney J Ho @RJ_Ho1]

Please help with finding people who are passionate about making Global impact on eliminating HIV through Long-acting and targeted, drug combination treatment. Our team is looking for talented scientist in both formulation know-how and bioanalytical exper…https://t.co/NIFHir2TGb

[Rodney J Ho @RJ_Ho1]

We are excited to share this opportunity at UW Pharmaceutics. The newly created Tenure Track Assistant Position is intended to recruit and mentor an outstanding NextGen Scientist with passion to teach students at UW. Areas of focus includes of drug deliv…https://t.co/n5lfjdaNG5

[Rodney J Ho @RJ_Ho1]

Students, Post-doc, Scientists, PI, Sponsors, Supporters and Community Advocates are encourage to attend on site or remotely Tuesday March 8. All are welcome. WE-REACH supported PIs, Student and team members will share about their experience working with…https://t.co/SToKJnbAaU

[Rodney J Ho @RJ_Ho1]

All are welcome. WE-REACH supported PIs, Student and team members will share about their experience working with WE-REACH in successfully moving ideas into innovative products to make health impact. Students, Post-doc, Scientists, PI, Sponsors, Supporter…https://t.co/4S6x7rBsAm

[Rodney J Ho @RJ_Ho1]

You are invited to join WE-REACH show case in-person at Forge Building University of Washingotn on Marcy 8, 2022. Students, Post-docs, Scientists, PIs, Sponsors, Supporters and Community advocates are invited to register and attend in-person or online.

[Rodney J Ho @RJ_Ho1]

Check out "WE-REACH Biomedical Innovation Showcase" https://t.co/p2ZrAKe6Db @Eventbrite

[Rodney J Ho @RJ_Ho1]

Wonderful news and opportunity for #uw and community. https://t.co/QCwDrVFxXt

[Rodney J Ho @RJ_Ho1]

Please spread the news and help recruit your colleague to consider joining our team in making global impact on HIV and on the path to finding a cure. #recruit #pharmaceutical #scientists #jobs https://t.co/tXnSE5SQRp

[Rodney J Ho @RJ_Ho1]

University of Washington #UWSOP TLC-ART, Targeted, Long-acting, Drug-Combination Therapeutic Program is #recruiting #pharmaceutical #scientists at all levels. inquire with Matthew Hartman #TLC-ART. Available Immediately. Here is the link…https://t.co/hb4mGaGfTr

[Rodney J Ho @RJ_Ho1]

@uwnews featured a report about @UW_Pharmacy's Drug Interaction database team being awarded by the @ASCPT American Association for Clinical Pharmacology and Therapeutics. Very proud of the team led by Isabelle Ragueneau-Majlessi. Congratulation

[Rodney J Ho @RJ_Ho1]

The Medicines Patent Pool and the U Washington-TLC-ART program sign a licence agreement for enabling technology that transform short-to-long-acting injectable HIV drug combination candidate intended for worldwide access-very GLAD https://t.co/VnwMUFpLGo